Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes. [electronic resource]
Producer: 20210617Description: 320-328 p. digitalISSN:- 1665-2681
- Carcinoma, Hepatocellular -- complications
- Diabetes Mellitus, Type 2 -- complications
- Disease-Free Survival
- Hepatectomy
- Humans
- Hypoglycemic Agents -- therapeutic use
- Liver Neoplasms -- complications
- Metformin -- therapeutic use
- Progression-Free Survival
- Radiofrequency Ablation
- Radiosurgery
- Sulfonylurea Compounds -- therapeutic use
- Survival Rate
- Thiazolidinediones -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.